Mostofsky, E.Lipsitch, MarcRegev-Yochay, Gili2018-06-222011Mostofsky, E., M. Lipsitch, and G. Regev-Yochay. 2011. “Is Methicillin-Resistant Staphylococcus Aureus Replacing Methicillin-Susceptible S. Aureus?” Journal of Antimicrobial Chemotherapy 66 (10) (July 7): 2199–2214. doi:10.1093/jac/dkr278.0305-7453http://nrs.harvard.edu/urn-3:HUL.InstRepos:37147305Despite extensive research on the emergence of and treatments for methicillin-resistant Staphylococcus aureus (MRSA), prior studies have not rigorously evaluated the impact of methicillin resistance on the overall incidence of S. aureus infections. Yet, there are direct clinical and research implications of determining whether methicillin-susceptible S. aureus (MSSA) infection rates remain stable in the face of increasing MRSA prevalence or whether MSSA will be replaced over time. A synthesis of prior studies indicates that the emergence of healthcare-associated MRSA (HA-MRSA) and community-associated MRSA (CA-MRSA) has led to an increase in the overall incidence of S. aureus infections, with MRSA principally adding to, rather than replacing, MSSA. However, colonization with CA-MRSA may at least partially replace colonization with MSSA. So far, evidence indicates that MSSA still accounts for many infections. Therefore, eradication of MRSA alone is not sufficient to address the public health burden of S. aureus.en-USbacterial resistancestaphylococcal infectionshealthcare-associated infectionscommunity-associated infectionsJournal Article2015-12-31Marc Lipsitch10.1093/jac/dkr278